A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
This perspective was adapted from a Career Achievement Award talk given at the International Cannabinoid Research Society Symposium in Bukovina, Poland on June 27, 2016. As a biochemist working in the neurosciences, I was always fascinated with neurotransmitter inactivation. In 1993 we identified an...
Saved in:
Main Author: | Dale Deutsch (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
by: Julius T. Dongdem, et al.
Published: (2022) -
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
by: Naresh Sunduru, et al.
Published: (2017) -
Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity
by: Rief Winfried, et al.
Published: (2010) -
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
by: Alessandro Deplano, et al.
Published: (2019) -
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
by: Justin Matheson, et al.
Published: (2021)